- Home
- HOOK
HOOK
HOOKIPA Pharma Inc.
as 03-28-2025 4:00pm EST
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 18.1M | IPO Year: | 2019 |
| Target Price: | $10.67 | AVG Volume (30 days): | 49.2K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.11 - $10.50 | Next Earning Date: | 05-08-2025 |
| Revenue: | $43,946,000 | Revenue Growth: | 118.32% |
| Revenue Growth (this year): | -55.32% | Revenue Growth (next year): | -94.81% |
Latest HOOKIPA Pharma Inc. News
HOOK Breaking Stock News: Dive into HOOK Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)
TipRanks
2 months ago
Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial
GlobeNewswire
2 months ago
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
MT Newswires
3 months ago
HC Wainwright Downgrades HOOKIPA Pharma to Neutral From Buy
GlobeNewswire
3 months ago
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
GlobeNewswire
3 months ago
HOOKIPA Pharma Inc - FORM 8 (OPD)
GlobeNewswire
3 months ago
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
GlobeNewswire
3 months ago
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
Compare HOOK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HOOK HOOKIPA Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.